中文版 | English

在结果中检索

IMR OpenIR

浏览/检索结果: 共108条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Gastric Cancer Models Developed via GelMA 3D Bioprinting Accurately Mimic Cancer Hallmarks, Tumor Microenvironment Features, and Drug Responses 期刊论文
SMALL, 2025, 页码: 20
作者:  Ju, Mingguang;  Jin, Zhizhong;  Yu, Xue;  Huang, Caihao;  Li, Yanshu;  Gao, Ziming;  Li, He;  Huang, Haibo;  Zheng, Chen;  Jia, Shiheng;  Zhang, Yixiao;  Liu, Xiaofang;  Zhou, Heng;  Zhang, Xing;  Li, Kai
收藏  |  浏览/下载：3/0  |  提交时间：2025/04/27
3D bioprinting  3D Cultures  Gastric Cancer  GelMA  Tumor Models  
Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2020, 卷号: 12, 页码: 10411-10421
作者:  Zeng, Guoming;  Jin, Libo;  Ying, Qinsi;  Chen, Haojie;  Thembinkosi, Murinda Charmaine;  Yang, Chunguang;  Zhao, Jinlong;  Ji, Hao;  Lin, Sue;  Peng, Renyi;  Zhang, Maolan;  Sun, Da
收藏  |  浏览/下载：137/0  |  提交时间：2021/02/02
cancer immunotherapy  Treg cells  FoxP3  targeting Treg cells  anti-cancer  
Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2020, 卷号: 12, 页码: 10411-10421
作者:  Zeng, Guoming;  Jin, Libo;  Ying, Qinsi;  Chen, Haojie;  Thembinkosi, Murinda Charmaine;  Yang, Chunguang;  Zhao, Jinlong;  Ji, Hao;  Lin, Sue;  Peng, Renyi;  Zhang, Maolan;  Sun, Da
收藏  |  浏览/下载：127/0  |  提交时间：2021/02/02
cancer immunotherapy  Treg cells  FoxP3  targeting Treg cells  anti-cancer  
KAI1 reverses the epithelial-mesenchymal transition in human pancreatic cancer cells 期刊论文
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 卷号: 18, 期号: 5, 页码: 471-477
作者:  Liu Xu;  Guo XiaoZhong;  Li HongYu;  Chen Jiang
收藏  |  浏览/下载：143/0  |  提交时间：2021/02/26
EXPRESSION  METASTASIS  ACTIVATION  VIMENTIN  ADHESION  SNAIL  KAI1  Epithelial-mesenchymal transition  Pancreatic cancer  
Engineering Gold Nanorod-Copper Sulfide Heterostructures with Enhanced Photothermal Conversion Efficiency and Photostability 期刊论文
SMALL, 2018, 卷号: 14, 期号: 12, 页码: -
作者:  Leng, CB;  Zhang, X;  Xu, FX;  Yuan, Y;  Pei, H;  Sun, ZH;  Li, L;  Bao, ZH;  Bao, ZH (reprint author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Liaoning, Peoples R China.;  Li, L (reprint author), East China Normal Univ, Sch Chem & Mol Engn, Shanghai 200241, Peoples R China.
收藏  |  浏览/下载：160/0  |  提交时间：2018/06/05
Core-shell  Cancer-treatment  Nanoparticles  Nanocrystals  Therapy  Oxide  Agent  Nanomaterials  Absorption  Electrodes  
Annual cost of illness of stomach and esophageal cancer patients in urban and rural areas in China: A multi-center study 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30, 期号: 4, 页码: 139-+
作者:  Yang Zhixun;  Zeng Hongmei;  Xia Ruyi;  Liu Qian;  Sun Kexin;  Zheng Rongshou;  Zhang Siwei;  Xia Changfa;  Li He;  Liu Shuzheng;  Zhang Zhiyi;  Liu Yuqin;  Guo Guizhou;  Song Guohui;  Zhu Yigong;  Wu Xianghong;  Song Bingbing;  Liao Xianzhen;  Chen Yanfang;  Wei Wenqiang;  Zhuang Guihua;  Chen Wanqing
收藏  |  浏览/下载：130/0  |  提交时间：2021/02/02
ENDOSCOPIC SUBMUCOSAL DISSECTION  GASTRIC-CANCER  HEALTH-CARE  HOSPITAL COSTS  GASTROINTESTINAL CANCER  INSURANCE  MORTALITY  OUTCOMES  IMPACT  AGE  Cost of illness  stomach neoplasms  esophageal neoplasms  China  
Design, Synthesis and Biological Activities of N-(Furan-2-ylmethyl)-1H-indole-3-carboxamide Derivatives as Epidemal Growth Factor Receptor Inhibitors and Anticancer Agents 期刊论文
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 卷号: 33, 期号: 3, 页码: 365-372
作者:  Zhang Lan;  Deng Xinshan;  Wu Jiaofeng;  Meng Guangpeng;  Liu Congchong;  Chen Guzhou;  Zhao Qingchun;  Hu Chun
收藏  |  浏览/下载：149/0  |  提交时间：2021/02/02
MOLECULAR TARGETED DRUGS  TYROSINE KINASE  CANCER-CELLS  EGFR  RESISTANCE  POTENT  DISCOVERY  NSCLC  Anticancer activity  Epidemal growth factor receptor(EGFR) inhibitor  N-( Furan-2-ylmethyl)-1H-indole3-carboxamide derivative  
Design, Synthesis and Biological Activities of N-(Furan-2-ylmethyl)-1H-indole-3-carboxamide Derivatives as Epidemal Growth Factor Receptor Inhibitors and Anticancer Agents 期刊论文
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 卷号: 33, 期号: 3, 页码: 365-372
作者:  Zhang Lan;  Deng Xinshan;  Wu Jiaofeng;  Meng Guangpeng;  Liu Congchong;  Chen Guzhou;  Zhao Qingchun;  Hu Chun
收藏  |  浏览/下载：143/0  |  提交时间：2021/02/02
MOLECULAR TARGETED DRUGS  TYROSINE KINASE  CANCER-CELLS  EGFR  RESISTANCE  POTENT  DISCOVERY  NSCLC  Anticancer activity  Epidemal growth factor receptor(EGFR) inhibitor  N-( Furan-2-ylmethyl)-1H-indole3-carboxamide derivative  
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells 期刊论文
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
作者:  Qin MingZe;  Wang Lei;  Yan Shuang;  Ma JunJie;  Tian Ye;  Zhao YanFang;  Gong Ping
收藏  |  浏览/下载：156/0  |  提交时间：2021/02/02
TYROSINE KINASE INHIBITOR  LUNG-CANCER  RECEPTOR  T790M  MUTANT  MUTATION  Aminopyrimidines  EGFR T790M/L858R  Selectivity  Anti-resistance  Antiproliferative activity  
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells 期刊论文
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
作者:  Qin MingZe;  Wang Lei;  Yan Shuang;  Ma JunJie;  Tian Ye;  Zhao YanFang;  Gong Ping
收藏  |  浏览/下载：138/0  |  提交时间：2021/02/02
TYROSINE KINASE INHIBITOR  LUNG-CANCER  RECEPTOR  T790M  MUTANT  MUTATION  Aminopyrimidines  EGFR T790M/L858R  Selectivity  Anti-resistance  Antiproliferative activity